1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Product innovation in reagents for diagnostics
4.1.2 Increasing applications of Flow Cytometry in Clinical research
4.1.3 Emergence of new technologies in the field of Flow Cytometry
4.1.4 Stem cell research booming the market growth
4.2 Restraints
4.2.1 Reagent based complexities
4.2.2 Reluctance among the medical consultants of developing countries to adopt a new technology like flow cytometry
4.2.3 Expensive types of equipment hindering the growth of the market
4.2.4 Lack of awareness about the potential benefits of flow cytometry techniques
4.3 Opportunities
4.3.1 Increasing use in drug discovery
4.3.2 Increasing rise of HIV and Cancer cases
4.4 Challenges
4.4.1 Lack of end-user awareness about the utility of instrument
4.4.2 High on maintenance and operational costs
5. North America Flow Cytometry Market - By Type of Product
5.1 Instruments
5.1.1 Flow Cytometers
5.1.2 Centrifuges
5.1.3 Cell preparation Systems
5.1.4 Others
5.2 Systems and Kits
5.3 Reagents
5.4 Instrument Support Reagents
5.5 Fluorospheres
5.6 Softwares
5.7 Others
6. North America Flow Cytometry Market- By technology
6.1 Cell-based Flow Cytometry
6.2 Bead-based Flow Cytometry
6.3 Others
7. North America Flow Cytometry Market- By Application
7.1 Clinical Applications
7.1.1 Oncology
7.1.2 detection of minimal Residue disease
7.1.3 Organ Transplantation
7.1.4 Stem Cell
7.1.5 HIV
7.1.6 Blood Transfusion
7.2 Life Sciences and Biotechnology (Research and Development)
7.2.1 Immunophenotyping
7.2.2 Cell Sorting
7.2.3 Cell cycle analysis
7.2.4 Apoptosis
7.2.5 Cell Proliferation Assay
7.2.6 Intracellular Calcium flux
7.3.3 Others
8. North America Flow Cytometry Market- By End Users
8.1 Hospitals
8.2 Academia
8.3 Biotechnology
8.4 Pharmaceuticals
8.5 CRO
8.6 Others
9. North America Flow Cytometry Market- By Country
9.1. Introduction
9.2. USA
9.3. Canada
9.4. Mexico
10. Company Profiles
10.1 Danaher Corporation
10.2 Sony Biotechnology Inc.
10.3 Sysmex Partec GmbH
10.4 Affymetrix, Inc.
10.5 Merck KGAA
10.6 Thermo Fisher Scientific, Inc.
10.7 Becton, Dickinson and Company
10.8 Beckman Coulter
10.9 EMD Millipore
10.10 Life Technologies
10.11 Bio-Rad Laboratories
10.12 Miltenyi Biotech
10.13 Partec GMBH
10.14 TTP Labtech Ltd
10.15 Luminex Corporation
11. North America Flow Cytometry Market - Competitive Landscape
11.1 Market Share Analysis
11.2 Strategies Adopted by top companies
11.3 Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1 Insights of Industry Experts
12.2 Investment Opportunities
12.3 Analyst Opinion
13. Appendix
13.1 List of Tables
13.2 List of Figures
